New Delhi, January 08, 2025.
Taking the ‘GLP-1 receptor agonist’ class of anti-obesity drugs is related with lower rates of post-surgery complications in people with diabetes, according to a study.
GLP-1 receptor agonist, or GLP-1 RA, drugs help treat diabetes by weight loss, improving blood glucose levels and increasing insulin sensitivity, low levels of which are a risk factor for diabetes.
Researchers, led by those at Weill Cornell Medicine, the US, analysed hospital records of over 74,400 surgical procedures performed from February 2020 to July 2023 on nearly 22,000 patients with diabetes.
